Creekmur Asset Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$23.8K Hold
238
– – ﹤0.01% 416
2025
Q2
$19.7K Sell
238
-6
-2% -$479 ﹤0.01% 438
2025
Q1
$19.8K Hold
244
– – ﹤0.01% 400
2024
Q4
$22K Hold
244
– – 0.01% 323
2024
Q3
$24.1K Buy
244
+183
+300% +$18K 0.01% 323
2024
Q2
$5.66K Hold
61
– – ﹤0.01% 575
2024
Q1
$5.79K Sell
61
-57
-48% -$5.29K ﹤0.01% 542
2023
Q4
$10.5K Buy
+118
New +$8.76K ﹤0.01% 522

Other funds holding XBI

Creekmur Asset Management's XBI Position: Q3 2025 in Review

Creekmur Asset Management held its State Street SPDR S&P Biotech ETF (XBI) position steady in Q3 2025 at 238 shares worth $23.8K. The position accounts for ﹤0.01% of the portfolio, ranked #416.

Creekmur Asset Management first reported a position in XBI in Q4 2023 and has held it in 8 quarters since. The position peaked at $24.1K in Q3 2024. 656 funds tracked by Wall St. Rank hold XBI as of Q3 2025.

  • Creekmur Asset Management held 238 shares of State Street SPDR S&P Biotech ETF worth $23.8K as of Q3 2025.
  • Creekmur Asset Management left its State Street SPDR S&P Biotech ETF share count unchanged in Q3 2025.
  • State Street SPDR S&P Biotech ETF made up ﹤0.01% of Creekmur Asset Management's portfolio in Q3 2025, its #416 holding.
  • Creekmur Asset Management first reported a position in State Street SPDR S&P Biotech ETF in Q4 2023 and has held it in 8 quarters since.
  • Creekmur Asset Management's State Street SPDR S&P Biotech ETF position peaked at $24.1K in Q3 2024.
  • 656 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2025.

Based on Creekmur Asset Management's 13F filing for Q3 2025, filed 12 Nov 2025.